Literature DB >> 9210009

Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports.

J E García Sánchez1, M L Vazquez López, A M Blazquez de Castro, J A Perez Simon, N G Gutierrez, I T Martin, J A García-Rodríguez.   

Abstract

Two seriously neutropenic patients (a 23-year-old man with a promyelocytic acute myeloid leukemia [AML-M3] and a 77-year old male with an immature acute myeloid leukemia [AML-M1] diagnosis) with severe infections caused by Stenotrophomonas maltophilia were treated with aztreonam/clavulanic acid (2:1) combination. In the first patient the infection was caused by a multiresistant strain and in the second, by a strain with poor response to trimethoprim-sulfamethoxazole and other antimicrobial agents. After treatment with aztreonam/clavulanic acid both patients evolved favorably.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210009     DOI: 10.1179/joc.1997.9.3.238

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  2 in total

1.  Extended spectrum beta-lactamase reactions in Stenotrophomonas maltophilia.

Authors:  J Blahová; M Hupková-Lesická; K Králiková; V Krcméry
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

2.  Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates.

Authors:  Jeffrey C Jolliff; Jackie Ho; Jeremiah Joson; Arash Heidari; Royce Johnson
Journal:  Case Rep Infect Dis       Date:  2016-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.